Non-ionic Iodine Contrast Media Market
Non-ionic Iodine Contrast Media Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Non-ionic Iodine Contrast Media Market Size and Growth
The Non-ionic Iodine Contrast Media market is experiencing robust growth, driven by increased imaging procedures and advancements in healthcare technology. In 2023, the market size is estimated at approximately $2.1 billion, with a projected CAGR of 5.2% through 2030, reflecting rising demand across diagnostic imaging and therapeutic applications. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GE Healthcare
◍ Bayer
◍ Bracco Imaging
◍ Guerbet Group
◍ Hengrui Medicine
◍ Lantheus
◍ YRPG
◍ BeiLu Pharma
◍ Sanochemia
◍ Tyco Healthcare
◍ Imax
◍ Grupo Juste
◍ Daiichi Sankyo
◍ Takeda
◍ Fuji Pharma
◍ Towaseiyaku
◍ Hikari Pharmaceutical
The Non-ionic Iodine Contrast Media Market features key players like GE Healthcare and Bayer, focusing on innovative formulations for improved imaging. Companies enhance market growth through strategic partnerships and expanding product lines. Notable sales revenues include GE Healthcare at $19 billion and Bayer at $20 billion, driving industry advancement.
◍ Consentis Diagnostics GmbH
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Request Sample Report
By Product
Iohexol
Iodixanol
Iopamidol
Ioversol
Market Growth
Request Sample Report
$ X Billion USD
